Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Grimm

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
BJU International|January 14, 2012
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancerStephen Langley, Hashim U Ahmed, Bashar Al-Qaisieh, et al.
Danish Medical Journal|February 25, 2026
Regional differences in mortality among patients with ruptured intracranial aneurysms in DenmarkAgnes T Stauning, Tina N Munch, George F Mkoma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer ImmunotherapyBenjamin Ribba, Christophe Boetsch, Tapan Nayak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 1, 2022
Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model)Norman A Mazer, Carsten Hofmann, Dominik Lott, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 9, 2022
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic modelRoxana Aldea, Hans Peter Grimm, Ronald Gieschke, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 27, 2013
The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile miceTakayuki Sakurai, Ryo Takai, Heinrich Bürgin, et al.
Mabs|August 9, 2013
Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeysVladimir Vexler, Li Yu, Chandrasena Pamulapati, et al.
Pharmaceutics|December 28, 2021
Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial FluidMiro Julian Eigenmann, Tine Veronica Karlsen, Marek Wagner, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer|July 14, 2011
Outcomes after prostate brachytherapy are even better than predictedSteven J Frank, Lawrence B Levy, Marco van Vulpen, et al.
American Journal of Clinical Oncology|December 9, 2008
Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of the Pro-Qura databasePeter F Orio, Gregory S Merrick, Peter Grimm, et al.
BJU International|January 14, 2012
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancerStephen Langley, Hashim U Ahmed, Bashar Al-Qaisieh, et al.
Danish Medical Journal|February 25, 2026
Regional differences in mortality among patients with ruptured intracranial aneurysms in DenmarkAgnes T Stauning, Tina N Munch, George F Mkoma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Prediction of the Optimal Dosing Regimen Using a Mathematical Model of Tumor Uptake for Immunocytokine-Based Cancer ImmunotherapyBenjamin Ribba, Christophe Boetsch, Tapan Nayak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 1, 2022
Development of a quantitative semi-mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q-ATN model)Norman A Mazer, Carsten Hofmann, Dominik Lott, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 9, 2022
In silico exploration of amyloid-related imaging abnormalities in the gantenerumab open-label extension trials using a semi-mechanistic modelRoxana Aldea, Hans Peter Grimm, Ronald Gieschke, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|March 27, 2013
The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile miceTakayuki Sakurai, Ryo Takai, Heinrich Bürgin, et al.
Mabs|August 9, 2013
Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeysVladimir Vexler, Li Yu, Chandrasena Pamulapati, et al.
Pharmaceutics|December 28, 2021
Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial FluidMiro Julian Eigenmann, Tine Veronica Karlsen, Marek Wagner, et al.
Pageof 5